Company · CIK 0001819133 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Tango Therapeutics, Inc. · TNGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 7:41 pm EDT | Jessica NewcombPrincipal Accounting Officer | 8,200 | $24.22 | $198,613 | 59,121 | −12.2% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:01 pm EDT | Adam CrystalPresident, R&D | 27,000 | $22.37 | $603,909 | 115,743 | −18.9% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:01 pm EDT | Adam CrystalPresident, R&D | 27,000 | $5.20 | $140,400 | 142,743 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:01 pm EDT | Adam CrystalPresident, R&D | 27,000 | $27.24 | $735,517 | 115,743 | −18.9% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:01 pm EDT | Adam CrystalPresident, R&D | 27,000 | $5.20 | $140,400 | 142,743 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 7:23 pm EDT | Adam CrystalPresident, R&D | 27,000 | $29.59 | $798,908 | 115,743 | −18.9% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 7:23 pm EDT | Adam CrystalPresident, R&D | 27,000 | $5.20 | $140,400 | 142,743 | — | 10b5-1 |
| Jun 19, 2026 AForm 4 → | Jun 23, 6:10 pm EDT | Robert AzelbyDirector | 5,740 | — | — | 5,740 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 6:08 pm EDT | John B KetchumDirector | 4,000 | — | — | 24,937 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 6:01 pm EDT | Lesley Ann CalhounDirector | 4,000 | — | — | 16,500 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 5:55 pm EDT | Mace RothenbergDirector | 4,000 | — | — | 41,500 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 5:49 pm EDT | Sung LeeDirector | 570 | — | — | 22,870 | — | |
| Jun 1, 2026 SForm 4 → | Jun 3, 6:37 pm EDT | Adam CrystalPresident, R&D | 27,000 | $22.87 | $617,571 | 115,743 | −18.9% | 10b5-1 |
| Jun 1, 2026 MForm 4 → | Jun 3, 6:37 pm EDT | Adam CrystalPresident, R&D | 27,000 | $5.20 | $140,400 | 142,743 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 MForm 4 → | Sep 3, 4:01 pm EDT | Adam CrystalPresident, R&D | 27,000 | — | — | 260,040 | — | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:01 pm EDT | Adam CrystalPresident, R&D | 27,000 | — | — | 287,040 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 7:23 pm EDT | Adam CrystalPresident, R&D | 27,000 | — | — | 314,040 | — | 10b5-1 |
| Jun 19, 2026 AForm 4 → | Jun 23, 6:10 pm EDT | Robert AzelbyDirector | 35,910 | — | — | 35,910 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 6:08 pm EDT | John B KetchumDirector | 25,000 | — | — | 25,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 6:01 pm EDT | Lesley Ann CalhounDirector | 25,000 | — | — | 25,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 5:55 pm EDT | Mace RothenbergDirector | 25,000 | — | — | 25,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 5:49 pm EDT | Sung LeeDirector | 3,570 | — | — | 3,570 | — | |
| Jun 1, 2026 MForm 4 → | Jun 3, 6:37 pm EDT | Adam CrystalPresident, R&D | 27,000 | — | — | 341,040 | — | 10b5-1 |